Inés Zugasti

MD, Hematologist (Clínic de Barcelona)

[Queralt Salas @QueraltSalas]

🎉Proud to share a summary of our work on #frailty in #alloHCT candidates over the last years @drasalinasrhb ⁦@hematoclinicbcn⁩ . Tele-#prehabilitation can improve patient’s readiness before transplantation 🚀- The Lancet Haematology https://t.co/RbLkrrQt0Q

[Signal Transduction and Targeted Therapy (STTT) @sigtrans_sttt]

This review outlines #CARTcelltherapy in hematologic & solid #tumors, highlights challenges in #AML therapy, explores ongoing #ClinicalTrials, & discusses strategies to optimize AML therapy. @InesZugasti @idibaps @CarrerasIJC

#STTT #OpenAccess: https://t.co/f0DxYIOoF2

[ASH @ASH_hematology]

Excited about progress in an emerging area of hematology? Share research advances and spotlight those doing the work on an international stage at the 67th ASH Annual Meeting and Exposition!

Organize a poster walk: https://t.co/rC1roTbi0C

#ASH25 #Hematology

[Waggoner Lab @LabWaggoner]

Review: CAR-T cell therapy for cancer: current challenges and future directions
https://t.co/XZM5qeGIbT @Menendez_Lab @InesZugasti

[Hematologia Hospital Clínic Barcelona @hematoclinicbcn]

🎓Molt orgullosos de les nostres noves hematòlogues la Dra. Mar de Pablo, la Dra.Ares Guardia, i la Dra. Ines Zugasti. 🎉

Un plaer haver compartit aquests anys de residència amb vosaltres. Molta sort en el vostre futur laboral.

@hospitalclinic
#RESIDENTSClínic

[Hematologia Hospital Clínic Barcelona @hematoclinicbcn]

🤔 Vols saber què t’ofereix la residència d'Hematologia i Hemoteràpia al #CLÍNIC❓

🩺 T’esperem el 20 de març a la Jornada de Portes Obertes!

👉 https://t.co/DQGJZVcQPM
#residentsCLÍNIC

[Alexandra Martínez-Roca. MD. @AMartinezRocaMD]

Thrilled to share our latest study: “At-Home (AH) care program for Acute Myeloid Leukemia (AML) patients undergoing induction therapy with Venetoclax + Azacitidine (VenAza)
🧵

https://t.co/JlZXc3XYUf #mdpicancers via @Cancers_MDPI

[Carlos Fernandez de Larrea @fdezdelarrea]

Just online our experience with PET/CT evaluation after ARI0002h in patients with myeloma in Spain. PFS and OS were shorter with extramedullary plasmacytomas. Survival was predicted by metabolic tumor volume at baseline; response on day 100 was very important @BloodAdvances

[Wei Ying Jen @jenweiying]

It is with deep sorrow that we bid our brother @AlmanzaLeukMD farewell today. A brilliant leukemia physician @MDAndersonNews whose light shone so bright; the world is so much darker now.

Please donate to help his family, whom he supported, with costs: https://t.co/sNBnDHiM4a

[CaixaResearch @CaixaResearch]

1/🧫 La terapia CAR-T ARI0002h, desarrollada en el @hospitalclinic-@idibaps con el apoyo de @FundlaCaixa, ya cuenta con la aprobación de @AEMPSgob para su uso en pacientes con mieloma múltiple resistentes a tratamientos convencionales.

Sigue leyendo.🧵👇

https://t.co/cn3PlzZ2e1

[Carlos Fernandez de Larrea @fdezdelarrea]

Just online! Serum mass spectrometry for treatment monitoring in patients with multiple myeloma receiving ARI0002h CAR T‐cells https://t.co/YtUwd935vG @BrJHaem @idibaps @hematoclinicbcn @hospitalclinic @immunoclinicbcn @InakiOdlp @ainitaoliver @BrunoPaiva_UNAV @vivamarta

[Eduardo Arellano-Rodrigo, MD @ArellanoRodrig0]

Just published our letter to the @EMERGENCIAS_NET editor on Acquired hemophilia A after SARS-CoV-2 infection: a causal or casual association?

@hematoclinicbcn
@InesZugasti #AresGuardia @raaulasoo #AdrianaCuartas @MdNomde

https://t.co/jJjcKnbT1L

[Amer Zeidan عامر زيدان @Dr_AmerZeidan]

Very impressive overview of European and international cooperative clinical trials in #MDSsm at #ESHMDS2024 @ESHaematology in #EMSCO with a great panel discussion by top leaders in the field

[Inés Zugasti @InesZugasti]

@ArellanoRodrig0 @hematoclinicbcn @MdNomde @EMERGENCIAS_NET @raaulasoo #AresGuardia #AdrianaCuartas

[Inés Zugasti @InesZugasti]

@AlmanzaLeukMD You're missing the @aporagua part. Definitely a lifechanging experience

[Inés Zugasti @InesZugasti]

@Dr_Ivanoncologo @mozasp @WomenInLymphoma @HemOncWomenDocs @andrearivero91 Congratulations!

[Dr. Iván R. González @Dr_Ivanoncologo]

Excellent review on updating and new therapeutic options in the treatment of #lymphoma.
https://t.co/Y8dIbSu9an

[Inés Zugasti @InesZugasti]

@edumesye Enhorabuena y bienvenido!!

[Inés Zugasti @InesZugasti]

@marinacg___ Bienvenida!!!

[Inés Zugasti @InesZugasti]

@MdePabloMiro @SETS_es Felicitats!!! 🩸🩸🩸